- €3.29bn
- €866.73m
- €2.78bn
- 45
- 41
- 35
- 32
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,331 | 1,589 | 2,669 | 2,742 | 2,782 |
Cost of Revenue | |||||
Gross Profit | 228 | 309 | 506 | 495 | 469 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,347 | 1,572 | 2,584 | 2,654 | 2,690 |
Operating Profit | -15.7 | 17.8 | 85 | 88.1 | 91.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -22.6 | 15.2 | 75.4 | 83.7 | 153 |
Provision for Income Taxes | |||||
Net Income After Taxes | -30.5 | -0.043 | 108 | 49.2 | 85.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -30.5 | -0.043 | 108 | 49.2 | 85.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -30.5 | -0.043 | 108 | 49.2 | 85.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.048 | 0.002 | 0.179 | 0.092 | 0.153 |
Dividends per Share |